Cargando…
Three Tiers to biological escape velocity: The quest to outwit aging
As longevity companies emerge with new products and the fields of anti‐aging research develop new cutting‐edge therapies, three distinct classes of longevity methodologies emerge. This discussion finds that there are three clear classes (Tiers) of longevity systems that are currently under developme...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805293/ https://www.ncbi.nlm.nih.gov/pubmed/36606268 http://dx.doi.org/10.1002/agm2.12231 |
_version_ | 1784862309921849344 |
---|---|
author | Palmer, Raymond D. |
author_facet | Palmer, Raymond D. |
author_sort | Palmer, Raymond D. |
collection | PubMed |
description | As longevity companies emerge with new products and the fields of anti‐aging research develop new cutting‐edge therapies, three distinct classes of longevity methodologies emerge. This discussion finds that there are three clear classes (Tiers) of longevity systems that are currently under development, and all three will be paramount to achieve biological escape velocity (where tissues can be repaired faster than aging can damage them). These classes are referred to as Tier 1, Tier 2, and Tier 3 treatments and are described in detail below. These three Tiers are required for easy identification for pharmaceutical companies and research companies to determine the type of therapy they may choose to deliver being noninvasive, invasive, time consuming, or simple end user products. Specific targets and goals need to be defined clearly from an early perspective in the development of these technologies for future precision medicines. This allows consumers of future anti‐aging technologies to consider which Tier a particular therapy may be, delivering a more informed choice. |
format | Online Article Text |
id | pubmed-9805293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98052932023-01-04 Three Tiers to biological escape velocity: The quest to outwit aging Palmer, Raymond D. Aging Med (Milton) Review Articles As longevity companies emerge with new products and the fields of anti‐aging research develop new cutting‐edge therapies, three distinct classes of longevity methodologies emerge. This discussion finds that there are three clear classes (Tiers) of longevity systems that are currently under development, and all three will be paramount to achieve biological escape velocity (where tissues can be repaired faster than aging can damage them). These classes are referred to as Tier 1, Tier 2, and Tier 3 treatments and are described in detail below. These three Tiers are required for easy identification for pharmaceutical companies and research companies to determine the type of therapy they may choose to deliver being noninvasive, invasive, time consuming, or simple end user products. Specific targets and goals need to be defined clearly from an early perspective in the development of these technologies for future precision medicines. This allows consumers of future anti‐aging technologies to consider which Tier a particular therapy may be, delivering a more informed choice. John Wiley and Sons Inc. 2022-12-12 /pmc/articles/PMC9805293/ /pubmed/36606268 http://dx.doi.org/10.1002/agm2.12231 Text en © 2022 The Author. Aging Medicine published by Beijing Hospital and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Review Articles Palmer, Raymond D. Three Tiers to biological escape velocity: The quest to outwit aging |
title | Three Tiers to biological escape velocity: The quest to outwit aging |
title_full | Three Tiers to biological escape velocity: The quest to outwit aging |
title_fullStr | Three Tiers to biological escape velocity: The quest to outwit aging |
title_full_unstemmed | Three Tiers to biological escape velocity: The quest to outwit aging |
title_short | Three Tiers to biological escape velocity: The quest to outwit aging |
title_sort | three tiers to biological escape velocity: the quest to outwit aging |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805293/ https://www.ncbi.nlm.nih.gov/pubmed/36606268 http://dx.doi.org/10.1002/agm2.12231 |
work_keys_str_mv | AT palmerraymondd threetierstobiologicalescapevelocitythequesttooutwitaging |